Moreover, since dysregulation of the JAK-STAT pathway is implicated in numerous chronic inflammatory skin conditions, it is not surprising that mounting evidence supports the efficacy of JAK inhibitors in other diseases, such as alopecia areata, hidradenitis suppurativa and vitiligo. The gene discussed is SOAT1; the disease is hidradenitis suppurativa.